GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Zhejiang Taimei Medical Technology Co Ltd (HKSE:02576) » Definitions » Cash Ratio

Zhejiang Taimei Medical Technology Co (HKSE:02576) Cash Ratio : 2.98 (As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Zhejiang Taimei Medical Technology Co Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Zhejiang Taimei Medical Technology Co's Cash Ratio for the quarter that ended in Dec. 2023 was 2.98.

Zhejiang Taimei Medical Technology Co has a Cash Ratio of 2.98. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Zhejiang Taimei Medical Technology Co's Cash Ratio or its related term are showing as below:

HKSE:02576' s Cash Ratio Range Over the Past 10 Years
Min: 2.98   Med: 3.6   Max: 4.1
Current: 4.1

During the past 4 years, Zhejiang Taimei Medical Technology Co's highest Cash Ratio was 4.10. The lowest was 2.98. And the median was 3.60.

HKSE:02576's Cash Ratio is ranked better than
91.78% of 669 companies
in the Healthcare Providers & Services industry
Industry Median: 0.58 vs HKSE:02576: 4.10

Zhejiang Taimei Medical Technology Co Cash Ratio Historical Data

The historical data trend for Zhejiang Taimei Medical Technology Co's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Taimei Medical Technology Co Cash Ratio Chart

Zhejiang Taimei Medical Technology Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Cash Ratio
4.00 3.60 2.98 4.10

Zhejiang Taimei Medical Technology Co Semi-Annual Data
Dec21 Dec22 Dec23 Dec24
Cash Ratio 4.00 3.60 2.98 4.10

Competitive Comparison of Zhejiang Taimei Medical Technology Co's Cash Ratio

For the Health Information Services subindustry, Zhejiang Taimei Medical Technology Co's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Taimei Medical Technology Co's Cash Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Zhejiang Taimei Medical Technology Co's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Taimei Medical Technology Co's Cash Ratio falls into.


;
;

Zhejiang Taimei Medical Technology Co Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Zhejiang Taimei Medical Technology Co's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=1168.137/391.43
=2.98

Zhejiang Taimei Medical Technology Co's Cash Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash Ratio (Q: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=1168.137/391.43
=2.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Taimei Medical Technology Co  (HKSE:02576) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Zhejiang Taimei Medical Technology Co Cash Ratio Related Terms

Thank you for viewing the detailed overview of Zhejiang Taimei Medical Technology Co's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Taimei Medical Technology Co Business Description

Traded in Other Exchanges
N/A
Address
36 Changsheng South Road, 3rd Floor, Building 9, Smart Industry Innovation Park, Zhejiang, Jiaxing, CHN
Zhejiang Taimei Medical Technology Co Ltd is a digital solution provider focused on the pharmaceutical and medical device industry in China, It designs and delivers industry-specific software and digital services that facilitate the research and development (R&D) as well as the commercialization of pharmaceuticals and medical devices. The software It offers is cloud-based, allowing users to access it from various devices at any time over the internet, without the need for software installation and maintenance on their devices. These cloud-based software covers critical use cases in R&D and commercialization of innovative drugs and medical devices.
Executives
Zuo Lingye 2201 Interest of corporation controlled by you
Shang Hai Jing Wei Gu Quan Tou Zi Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Hang Zhou Jing Wei Yuan Chuang Tou Zi Guan Li He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Jing Wei Chuang Teng Hang Zhou Chuang Ye Tou Zi He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Shen Zhen Shi Teng Xun Rui Tou Qi Ye Guan Li You Xian Gong Si
Teng Xun Ke Ji Shen Zhen You Xian Gong Si
Chen Yihai 2202 Interest of your spouse
Shang Hai Chen Xi Chuang Ye Tou Zi Zhong Xin You Xian He Huo 2101 Beneficial owner
Shang Hai Yuan Pan Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Xue Qiong 2201 Interest of corporation controlled by you
Ma Huateng
Lin Zhi Teng Xun Tou Zi Guan Li You Xian Gong Si
Shen Zhen Shi Teng Xun Chan Ye Tou Zi Ji Jin You Xian Gong Si
Oriental Power Holdings Limited
Shen Zhen Shi Teng Xun Rui Jian Tou Zi You Xian Gong Si

Zhejiang Taimei Medical Technology Co Headlines

No Headlines